These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 11092702

  • 21. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F, Cobellis L, Mele D, Tassou A, Badolati B, Sorrentino S, De Lucia D, Colacurci N.
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [Abstract] [Full Text] [Related]

  • 22. Organic hydroperoxide-induced chemiluminescence of follicular fluid and blood serum samples obtained from women pretreated for in vitro fertilization.
    Török A, Németh P, Török B, Berki T, Tinneberg HR, Bódis J.
    Gynecol Obstet Invest; 2004 Jan; 57(2):72-9. PubMed ID: 14671414
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist.
    Cunha-Filho JS, Lemos N, Stein N, Laranjeira A, Passos EP.
    Fertil Steril; 2005 Apr; 83(4):902-7. PubMed ID: 15820798
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ, Iles RK, Iammarrone E, Gillott CM, Al-Shawaf T, Grudzinskas JG.
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [Abstract] [Full Text] [Related]

  • 28. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.
    Seow KM, Juan CC, Hsu YP, Ho LT, Wang YY, Hwang JL.
    Hum Reprod; 2005 Jan; 20(1):117-21. PubMed ID: 15513972
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Correlation of reactive oxygen species levels with the fertilization rate after in vitro fertilization: a qualified meta-analysis.
    Agarwal A, Allamaneni SS, Nallella KP, George AT, Mascha E.
    Fertil Steril; 2005 Jul; 84(1):228-31. PubMed ID: 16009190
    [Abstract] [Full Text] [Related]

  • 31. Reactive oxygen species (ROS): involvement in bovine follicular cysts etiopathogenesis.
    Rizzo A, Minoia G, Trisolini C, Mutinati M, Spedicato M, Jirillo F, Sciorsci RL.
    Immunopharmacol Immunotoxicol; 2009 Jul; 31(4):631-5. PubMed ID: 19874233
    [Abstract] [Full Text] [Related]

  • 32. Epidermal growth factor and leukemia inhibitory factor levels in follicular fluid. Association with in vitro fertilization outcome.
    Ozörnek MH, Bielfeld P, Krüssel JS, Hirchenhain J, Jeyendran RS, Koldovsky U.
    J Reprod Med; 1999 Apr; 44(4):367-9. PubMed ID: 10319308
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The association between microenvironmental reactive oxygen species and embryo development in assisted reproduction technology cycles.
    Lee TH, Lee MS, Liu CH, Tsao HM, Huang CC, Yang YS.
    Reprod Sci; 2012 Jul; 19(7):725-32. PubMed ID: 22378864
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfield M, Visser JA, Themmen AP, Groome NP.
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.